NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000004847

Registered date:15/01/2011

The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplasty

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedPost hip arthroplasty
Date of first enrollment2007/04/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Medication with Alendronate Control

Outcome(s)

Primary OutcomeThe change of bone mineral density in the acetabulum and proximal femur
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaMetabolic bone disease except for osteopolosis, taking medications that could affect bone turnover (such as bisphosphonates, active vitamin D3, estrogen, calcitonin, SERM, ipriphrabones, vitamin K), renal disfunction.

Related Information

Contact

public contact
Name Yuko Sakamoto
Address Japan
Telephone
E-mail u-sakamo@juntendo.ac.jp
Affiliation Juntendo University Nerima Hospital Dept. of Orthopaedics
scientific contact
Name Masahiko Nozawa
Address 3-1-10 Takanodai Nerima-ku Tokyo Japan
Telephone 03-5923-3111
E-mail
Affiliation Juntendo University Nerima Hospital Dept. of Orthopaedics